BarnettM.H.SuttonI.The pathology of multiple sclerosis: a paradigm shiftCurr Opin Neurol2006; 19:242–247.
2.
TanI.L.van SchijndelR.A.PouwelsP.J.MR venography of multiple sclerosisAJNR Am J Neuroradiol2000; 21:1039–1042.
3.
GeY.ZohrabianV.M.GrossmanR.I.Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosisArch Neurol2008; 65:812–816.
4.
GeY.ZohrabianV.M.OsaE.O.Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 TeslaJ Magn Reson Imaging2009; 29:1190–1194.
5.
ZamboniP.GaleottiR.MenegattiE.Chronic cerebrospinal venous insufficiency in patients with multiple sclerosisJ Neurol Neurosurg Psychiatry2009; 80:392–399.
6.
ZamboniP.GaleottiR.MenegattiE.A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiencyJ Vasc Surg2009; 50:1348–1358.
7.
HaackeE.M.ChengbN.Y.C.HouseM.J.Imaging iron stores in the brain using magnetic resonance imagingMagn Reson Imaging2005; 23:1–25.
8.
PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study GroupRandomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosisLancet1998; 352:1498–1503.
9.
FischerB.H.MarksM.ReichT.N.Hyperbaric-oxygen treatment of multiple sclerosis: a randomized, placebo-controlled, double-blind studyN Engl J Med1983; 308:181–186.
